Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,910
Closed -$89.3K 503
2025
Q1
$89.3K Hold
1,910
0.02% 195
2024
Q4
$97.8K Hold
1,910
0.02% 190
2024
Q3
$84.9K Buy
1,910
+1,000
+110% +$43.7K 0.02% 201
2024
Q2
$36.6K Hold
910
0.01% 250
2024
Q1
$36.5K Hold
910
0.01% 265
2023
Q4
$34.3K Hold
910
0.01% 261
2023
Q3
$25.3K Hold
910
0.01% 276
2023
Q2
$27.5K Buy
+910
New +$26.6K 0.01% 279
2022
Q4
Sell
-1,000
Closed -$37.5K 557
2022
Q3
$37.5K Hold
1,000
0.01% 228
2022
Q2
$36K Hold
1,000
0.01% 244
2022
Q1
$49K Hold
1,000
0.02% 226
2021
Q4
$47.9K Hold
1,000
0.01% 236
2021
Q3
$43.9K Buy
+1,000
New +$42.3K 0.02% 223

Other funds holding SNV

West Paces Advisors's SNV Position: Q2 2025 in Review

West Paces Advisors sold out of Synovus (SNV) in Q2 2025, closing a stake of 1,910 shares — an estimated $89.3K sold.

West Paces Advisors first reported a position in SNV in Q3 2021 and held it in 13 quarters. The position peaked at $97.8K in Q4 2024. 475 funds tracked by Wall St. Rank hold SNV as of Q2 2025.

  • West Paces Advisors reported no remaining Synovus position as of Q2 2025 after selling out during the quarter.
  • West Paces Advisors sold 1,910 Synovus shares in Q2 2025, an estimated $89.3K.
  • West Paces Advisors first reported a position in Synovus in Q3 2021 and held it in 13 quarters.
  • West Paces Advisors's Synovus position peaked at $97.8K in Q4 2024.
  • 475 funds tracked by Wall St. Rank held Synovus as of Q2 2025.

Based on West Paces Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.